HUG project leader Cem Gabay, , Department, division Spécialités de Médecine, Rhumatologie / / e-mail email@example.com, , Country partner Cameroun Project partner abroad Madeleine Ngandeu, , Department, division Médecine Interne, Rhumatologie / / Institution Hôpital Central&Faculté de Médecine, Yaoundé, Cameroun / / e-mail firstname.lastname@example.org, , Starting date 01/04/2008 Ending date The collaboration project started with the training of Dr Ngandeu as rheumatologist in Geneva in 2000. Professor Gabay then pursued the collaboration by regular visits in Yaoundé with the aim of teaching medical students and post-gardate trainees, as well as providing his expertise for the management of difficult cases (outpatient clinic and rounds). The two institutes also collaborated on a clinical research project on rheumatoid arthritis in Cameroun that included genetic and serological analysis. This research has been successful with several published papers. Dr Ngandeu was recently appointed as Professor and is acting as Vice-Dean at the Medical Faculty of Yaoundé. The collaboration is ongoing with visits of Prof. Gabay in Yaoundé, the training of another rheumatologist, and the extension of the research project to a larger cohort of patients followed in Doualla. ...
Feasibility and cost of pegylated liposomal doxorubicin for the treatment of AIDS-associated Kaposi’s sarcoma in Maputo, Mozambique
HUG project leader Laurence Toutous Trellu, , Department, division Service de dermatologie, HUG / / e-mail email@example.com, , Country partner Mozambique Project partner abroad Matthew Coldiron, Jean Paul Kimenyi, Lucas Molfino Department, division Epicentre- Médecins sans frontières / Médicos Sem Frontereiras / Médicos sem fronteiras Institution Médecins sans frontières / Médecins sans frontières Suisse / Médecins sans frontières Suisse e-mail firstname.lastname@example.org, MSFCH-Maputoemail@example.com, firstname.lastname@example.org Starting date 01/10/2015 Ending date 01/04/2017 Kaposi’s sarcoma (KS) is endemic in many countries of Africa and causes considerable morbidity and mortality in sub-Saharan Africa. The association with HIV infection and loss of immunity worsens the presentation of this tumor known to be associated to Herpes virus 8 (HHV8). Few treatment programs can effectively combat this burden. Some of the reasons for the lack of KS treatment programs are the absence of international guidelines and protocols adapted for resource deprived settings as well as high cost of modern treatment. We propose to introduce a new treatment for Kaposi’s Sarcoma patients at the MSF-CH supported Centro de Referencia do Alto-Maé in Maputo, Mozambique. Specifically, MSF-CH with approval of the Ministry of Health, proposes to substitute the standard therapy of doxorubicin, bleomycin and vincristine (ABV) with pegylated liposomal doxorubicin (PLD), which in clinical trials has been shown to be less toxic and more effective than the standard therapy, but not yet widely used in resource limited settings due to its high costs. Since PLD is not yet used in Mozambique, we here propose to implement it as part of a clinical study with the objective to document its effectiveness and safety in a resource-limited setting. ...
Noma is a disease causing great esthetic and functional sequelae in very young children in developing countries.
Jointly lead epidemiological and clinical research projects on neglected tropical diseases and chronic diseases.
Evaluate the Efficiency of a Multimodal Intervention in order to Make the Departments of Family Medicine more Welcoming for Young People in Bosnia and Herzegovina (Randomised Controlled Survey)
2010-2013: Randomized controlled intervention in 60 departments of family medicine in the canton of Zenica.
Courses on MD/PhD theses of Geneva students in various common scientific projects, organisation of scientific meetings.
Geneva-Beijing Tripartite Initiative Collaboration Agreement between the Faculty of Medicine of the University of Geneva and the Beijing Hospital in order to Promote Scientific Collaboration
Promote a scientific collaboration in fundamental and applied research in geriatrics, heart disease, diabetes, cell therapy and oxidative stress by the development of MD/PhD theses, pursue common research for projects and organise scientific collaborative meetings.
We established a 3 parts collaboration, responding to a specific request by our Vietnamese colleagues.
HUG project leader Pr Alain Malafosse Department, division Department of Genetics and Laboratory Medicine, Division of Genetic Psychiatry (HUG) and Department of Psychiatry (Faculty) e-mail email@example.com Country partner Algeria Project partner abroad Dr Aicha Dahdouh Department, division Institution University Hospital and Faculty of Medicine of Oran e-mail Starting date Ending date ...
Medical supervision and support to research projects and control of sleeping sickness and kala-azar in sub-saharan Africa since 1999.